InsidersTradesSigma
Track the MARIZYME, INC. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €40k. The latest transaction was reported on 28 December 2023 (C). Among the most active insiders: Lichti Braeden. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
MARIZYME, INC. is a NASDAQ-listed company focused on developing therapeutic solutions for serious diseases. It employs innovative technologies to enhance patient outcomes.